| Jul 20, 2026 | SCHEDULE 13G | Perspective Therapeutics, Inc. |
| Jul 1, 2026 | 8-K | Perspective Therapeutics, Inc. — 8-K |
| Jun 30, 2026 | SCHEDULE 13G | Perspective Therapeutics, Inc. |
| Jun 1, 2026 | 8-K | Perspective Therapeutics, Inc. — 8-K |
| May 27, 2026 | 8-K | Perspective Therapeutics, Inc. — 8-K |
| May 22, 2026 | 8-K | Perspective Therapeutics, Inc. — 8-K |
| May 12, 2026 | SCHEDULE 13G/A | Perspective Therapeutics, Inc. |
| May 11, 2026 | 10-Q | Perspective Therapeutics, Inc. — 10-Q |
| May 11, 2026 | 8-K | Perspective Therapeutics, Inc. — 8-K |
| May 4, 2026 | 8-K | Perspective Therapeutics, Inc. — 8-K |
| Apr 27, 2026 | SCHEDULE 13G/A | Perspective Therapeutics, Inc. |
| Apr 20, 2026 | 8-K | Perspective Therapeutics, Inc. — 8-K |
| Apr 16, 2026 | DEFA14A | Perspective Therapeutics, Inc. — DEFA14A |
| Apr 16, 2026 | DEF 14A | Perspective Therapeutics, Inc. — DEF 14A |
| Apr 1, 2026 | 8-K | Perspective Therapeutics, Inc. — 8-K |
| Mar 16, 2026 | 10-K | Perspective Therapeutics, Inc. — 10-K |
| Mar 16, 2026 | 8-K | Perspective Therapeutics, Inc. — 8-K |
| Mar 10, 2026 | SCHEDULE 13G | Perspective Therapeutics, Inc. |
| Mar 4, 2026 | 4×8 | Perspective Therapeutics, Inc. — 8 filings this day |
| Feb 12, 2026 | SCHEDULE 13G | Perspective Therapeutics, Inc. |
| Feb 9, 2026 | SCHEDULE 13G | Perspective Therapeutics, Inc. |
| Feb 6, 2026 | SCHEDULE 13G | Perspective Therapeutics, Inc. |
| Feb 5, 2026 | SCHEDULE 13G | Perspective Therapeutics, Inc. |
| Feb 3, 2026 | 8-K | Perspective Therapeutics, Inc. — 8-K |
| Feb 3, 2026 | 424B5 | Perspective Therapeutics, Inc. — 424B5 |
| Feb 2, 2026 | FWP | Perspective Therapeutics, Inc. — FWP |
| Feb 2, 2026 | 8-K | Perspective Therapeutics, Inc. — 8-K |
| Jan 14, 2026 | 8-K | Perspective Therapeutics, Inc. — 8-K |
| Jan 12, 2026 | 8-K | Perspective Therapeutics, Inc. — 8-K |
| Jan 9, 2026 | 8-K | Perspective Therapeutics, Inc. — 8-K |
| Dec 5, 2025 | SCHEDULE 13G/A | Perspective Therapeutics, Inc. |
| Dec 1, 2025 | 8-K | Perspective Therapeutics, Inc. — 8-K |
| Nov 17, 2025 | 4 | Perspective Therapeutics, Inc. — 4 |